Millennium Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
JT
CAM
Millennium Management's LGND Position: Q2 2026 in Review
Millennium Management opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 3,975 shares worth $1.26M. The stake represents ﹤0.01% of the portfolio and ranks #4171 among its holdings. This is a return to the name: Millennium Management previously reported a position in LGND as recently as Q1 2025.
Millennium Management first reported a position in LGND in Q2 2013 and has held it in 36 quarters since. The position peaked at $74.2M in Q4 2018. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Millennium Management held 3,975 shares of Ligand Pharmaceuticals worth $1.26M as of Q2 2026.
- Ligand Pharmaceuticals was a new Millennium Management position in Q2 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #4171 holding.
- Millennium Management first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 36 quarters since.
- Millennium Management's Ligand Pharmaceuticals position peaked at $74.2M in Q4 2018.
- 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.